Proteomics in Cardiovascular Biology

Proteomics is aimed at identifying and characterizing these protein changes and can be applied to the field of cardiovascular sciences, it has the potential to reveal those proteins that are associated with pathogenesis and could be potentially used as predictive or prognostic markers. Here is the latest research.

January 21, 2022
Open Access

Overexpression of the SARS-CoV-2 receptor angiotensin converting enzyme 2 in cardiomyocytes of failing hearts.

Scientific Reports
Kristina VukusicOla Hammarsten
January 21, 2022
Review

Omics era in type 2 diabetes: From childhood to adulthood.

World Journal of Diabetes
Antonio Paride PassaroAnna Di Sessa
January 21, 2022
Open Access

Nanoenviroments of the β-Subunit of L-Type Voltage-Gated Calcium Channels in Adult Cardiomyocytes.

Frontiers in Cell and Developmental Biology
Yiliam Cruz-GarciaErick Miranda-Laferte
January 21, 2022

Non-invasive imaging as the cornerstone of cardiovascular precision medicine.

European Heart Journal Cardiovascular Imaging
Stephan AchenbachSven Plein
January 21, 2022

Study on diverse pathological characteristics of heart failure in different stages based on proteomics.

Journal of Cellular and Molecular Medicine
Jinying LiuShuzhen Guo
January 20, 2022

Hypoxia Increases the Potential for Neutrophil-Mediated Endothelial Damage in COPD.

American Journal of Respiratory and Critical Care Medicine
Katharine M LodgeAlison M Condliffe
January 19, 2022
Preprint
Open Access

Mapping the Proteoform Landscape of Five Human Tissues

ChemRxiv
Bryon DrownNeil Kelleher
January 19, 2022

Association between greenness and dyslipidemia in patients with coronary heart disease: A proteomic approach.

Ecotoxicology and Environmental Safety
Jianhui GuoXiaoxu Xie
January 17, 2022

Myocardial Rev-erb-Mediated Diurnal Metabolic Rhythm and Obesity Paradox.

Circulation
Shiyang SongZheng Sun
January 17, 2022

Identification and characterization of post-translational modifications: Clinical implications.

Molecular Aspects of Medicine
Juliane HermannVera Jankowski
January 14, 2022

Hot topics in ischaemic heart disease: revascularization, hibernation, type 2 infarction, and proteomics.

European Heart Journal
Filippo Crea
January 14, 2022

Histologic and proteomic remodeling of the pulmonary veins and arteries in a porcine model of chronic pulmonary venous hypertension.

Cardiovascular Research
Ahmed U FayyazMargaret M Redfield
January 14, 2022
Open Access

The amniotic fluid proteome changes with gestational age in normal pregnancy: a cross-sectional study.

Scientific Reports
Gaurav BhattiAdi L Tarca
January 13, 2022

Carbonic anhydrase 2 and 3 as risk biomarkers for dilated cardiomyopathy associated heart failure.

Annals of Palliative Medicine
Hao SuJian Xu
January 13, 2022

Smooth muscle mineralocorticoid receptor as an epigenetic regulator of vascular aging.

Cardiovascular Research
Jaime IbarrolaIris Z Jaffe
January 12, 2022
Open Access

Multi-Omics Approach Profiling Metabolic Remodeling in Early Systolic Dysfunction and in Overt Systolic Heart Failure.

International Journal of Molecular Sciences
Antoine H ChaaninePatrice Delafontaine
January 12, 2022
Review
Open Access

OMICS in Chronic Kidney Disease: Focus on Prognosis and Prediction.

International Journal of Molecular Sciences
Michele ProvenzanoMichele Andreucci

Sign up to follow this feed and discover related papers.

Related Feeds

Adipose Tissue Heterogeneity

Examining the genomics, transcriptomics, proteomics, and metabolomics of adipose tissue at the single cell level will help build a single cell atlas of these tissues, providing insights into how changes in the map underlie health and disease states. Discover the latest research on adipose tissue heterogeneity here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Artificial Heart & Ventricular Assist Devices

Total artificial hearts (TAH) and ventricular assist devices (VADs) provide cardiac support for patients with end-stage heart disease and have significantly improved the survival of these patients. Discover the latest research on Artificial Heart and Ventricular Assist Devices here.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cardiac Electrophysiology

Cardiac electrophysiology is the study of electrical activities of the heart and includes the assessment, diagnosis, and treatment of cardiac events. Find the latest research on cardiac electrophysiology here.

Cardiac Glycosides

Cardiac glycosides are a diverse family of naturally derived compounds that bind to and inhibit na+/k+-atpase. Discover the latest research on cardiac glycosides heres.

© 2022 Meta ULC. All rights reserved
/feed-previews/proteomics-in-cardiovascular-biology/cbb14bb4-7e57-4b71-ae02-edecd046ce84